Vyvanse Price

Vyvanse (lisdexamfetamine) is a prescription medication commonly used in Australia to treat attention deficit hyperactivity disorder (ADHD) and moderate to severe binge eating disorder. If you or a loved one are considering Vyvanse, understanding its cost and availability in Australia is essential. This blog post provides an up-to-date overview of Vyvanse pricing, supply challenges, and tips for managing costs.

Current Pricing of Vyvanse in Australia

Vyvanse is not listed on the Pharmaceutical Benefits Scheme (PBS) in Australia, meaning it is only available through a private prescription. The price varies depending on the dosage strength and the pharmacy, but typical costs for a 30-capsule supply are approximately:

  • $90 to $115 for doses ranging from 30 mg to 50 mg per capsule

For example, Chemist Warehouse lists Vyvanse 40 mg capsules (30 count) at around $91.99, while some other pharmacies may charge closer to $115 for 50 mg capsules.

Supply and Availability Challenges

Since 2022, Australia has experienced a shortage of Vyvanse, particularly affecting the 30 mg strength but also impacting 40 mg, 50 mg, and 60 mg capsules. This shortage stems from global manufacturing delays and restrictions imposed by the US Drug Enforcement Administration (DEA) on the production of lisdexamfetamine’s active ingredients.

Pharmacies across Australia report difficulty maintaining stock, leading to longer wait times and occasional rationing. The Therapeutic Goods Administration (TGA) recommends prioritizing supply for ongoing patients to maintain treatment continuity.

Managing Costs and Alternatives

Because Vyvanse is not subsidized by PBS, the out-of-pocket cost can be significant. Here are some strategies to help manage expenses:

  • Talk to your doctor: Your healthcare provider may suggest alternative ADHD medications, some of which might be PBS-listed and more affordable.
  • Pharmacy shopping: Prices can vary between pharmacies, including online retailers, so comparing costs may save money.
  • Manufacturer assistance: In some countries, the manufacturer offers savings programs or coupons. While Australia-specific programs are limited, it’s worth inquiring with your pharmacist.
  • Splitting doses: Some doctors have advised patients to use higher-dose capsules and split them (e.g., dissolving capsules in water) to manage shortages and costs, but this should only be done under medical supervision.

Summary

Vyvanse is a valuable treatment for ADHD and binge eating disorder in Australia but comes with a relatively high cost due to its private prescription status and current supply shortages. Prices typically range from $90 to $115 for a month’s supply, with availability fluctuating due to manufacturing and regulatory challenges. Patients are encouraged to work closely with their healthcare providers and pharmacists to find the best treatment plan and manage costs effectively.